Table 2.
Characteristics of serum samples obtained from tick-borne encephalitis (TBE) patients in Austria, 2017, as determined by routine serodiagnosis.
| Sample | TBE IgM 1 | TBE IgG 1 | TBE NT 2 | YF NT 3 |
|---|---|---|---|---|
| T1 | >1000 | >1000 | pos | neg |
| T2 | 900 | >1000 | pos | neg |
| T3 | 567 | >1000 | pos | neg |
| T4 | 664 | >1000 | pos | neg |
| T5 | >1000 | >1000 | pos | neg |
| T6 | >1000 | >1000 | pos | neg |
| T7 | >1000 | >1000 | pos | neg |
| T8 | 968 | >1000 | pos | neg |
| T9 | 995 | >1000 | pos | neg |
| T10 | >1000 | >1000 | pos | neg |
| T11 | >1000 | >1000 | pos | neg |
| T12 | >1000 | >1000 | pos | neg |
| T13 | >1000 | >1000 | pos | neg |
| T14 | >1000 | >1000 | pos | neg |
| T15 | >1000 | >1000 | pos | neg |
| T16 | 829 | >1000 | pos | neg |
1 TBE virus-specific IgM and IgG were quantified in arbitrary units as described in Materials and Methods. All samples were IgM and IgG positive; 2 TBE neutralization test; 3 Yellow fever (YF) neutralization test.